Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein (HSIC) delivers essential healthcare products and services to dental, medical, and animal health practices worldwide. This news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives.
Track all official announcements through our curated collection of press releases and verified news coverage. Stay informed about earnings reports, product launches, partnership agreements, and operational milestones that shape Henry Schein's position in global healthcare distribution.
Key updates include acquisitions expanding service capabilities, technological innovations in supply chain management, and regulatory developments affecting medical device distribution. Our repository eliminates fragmented research by consolidating critical information from multiple sources.
Bookmark this page for efficient monitoring of HSIC's market activities. Return regularly to access new filings, leadership updates, and analysis of trends impacting healthcare providers and distributors.
Henry Schein (Nasdaq: HSIC) announced that CEO Stanley M. Bergman will retire at the end of 2025 after an impressive 45-year tenure, including over 35 years as CEO. Bergman will continue as Chairman after retirement while the Board initiates a formal search for his successor, considering both internal and external candidates.
Under Bergman's leadership, Henry Schein transformed from a small U.S. dental mail order company into a global healthcare solutions giant, growing revenue from $225 million in 1989 to nearly $13 billion in 2024 (17.5% CAGR). The company's market cap expanded from $290 million at its 1995 IPO to approximately $9 billion currently, delivering a 12.4% non-GAAP EPS CAGR.
The company has evolved into the largest global dental distributor, leading provider of dental practice management software, and second-largest provider of endodontic products, with higher-margin businesses now contributing over 50% of total non-GAAP operating income.
Henry Schein One (HSIC) has released its fourth annual Catalyst Index, a comprehensive report revealing key performance insights from the top 10% of dental practices. The report highlights that leading practices are achieving higher revenue and patient growth despite seeing fewer patients, primarily by focusing on improving patient experience.
Key findings show that nearly 60% of patients decline care due to poor education, pricing clarity, and experience issues. Top performers excel by offering faster appointments, streamlined forms, clear billing, and flexible scheduling. The report indicates that average practices significantly underutilize their revenue potential, with daily gross production approximately four times lower than top performers.
Henry Schein (NASDAQ: HSIC) has completed a significant $250 million strategic investment from KKR, resulting in KKR holding approximately 12% of Henry Schein's common shares. Following this transaction, two key appointments have been made to Henry Schein's Board of Directors: William K. "Dan" Daniel, KKR's Executive Advisor and former Danaher Corporation Executive VP, and Max Lin, KKR Partner and leader of the firm's Health Care industry team in the Americas.
Lin, appointed on May 2, 2025, will serve as Vice Chair of the Nominating and Governance Committee, while Daniel will join the Compensation Committee. Both executives will also serve on the Strategic Advisory Committee, bringing their extensive healthcare and operational expertise to support Henry Schein's BOLD+1 strategy.
Henry Schein (HSIC), the leading provider of healthcare solutions for dental and medical practitioners, has announced its participation in the upcoming Jefferies Global Healthcare Conference. The presentation is scheduled for June 4, 2025, at 1:20 p.m. Eastern time at the Marriott Marquis hotel in New York City. Investors can access the live webcast through Henry Schein's investor relations website, with replays available after the presentation.
Henry Schein (HSIC), the leading provider of healthcare solutions for dental and medical practitioners, has announced its participation in two major investor conferences in May 2025:
1. The Bank of America Healthcare Conference at the Encore Hotel in Las Vegas on May 14, 2025, at 10:00 a.m. PT (1:00 p.m. ET)
2. The Stifel Jaws & Paws Conference at Lotte Hotel, New York City, on May 29, 2025, at 12:40 p.m. ET
Both presentations will be accessible via live webcast on the company's website at www.henryschein.com/IRwebcasts, with replays available after the events.
Henry Schein Medical has announced Ian Jeffer, Head Athletic Trainer at Desert Ridge High School in Mesa, Arizona, as the winner of its fifth annual Rising Star Award for 2025. The award recognizes emerging athletic trainers with up to five years of experience in Sports Medicine.
Jeffer was selected for his exceptional care to students and management of a student sports medicine club that inspires future athletic trainers. The other finalists included Marissa Lucas from WellStar Health System and Cross Creek High School, and Angel Picart from American Heritage Schools.
The winner was chosen through public voting after being nominated by peers and selected by a Recognition Committee. As the recipient, Jeffer will receive a handheld muscle stimulator and a Medi Kit™ MULE roller bag with athletic training supplies.
Henry Schein (NASDAQ: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, has announced its upcoming first quarter 2025 financial results release. The company will disclose its Q1 2025 results before market opening on Monday, May 5th, 2025, followed by a live earnings conference call at 8:00 a.m. ET.
The earnings call will feature presentations from Stanley M. Bergman, Chairman of the Board and CEO, and Ronald N. South, Senior Vice President and CFO. Investors can access the webcast at investor.henryschein.com/webcasts, with a replay available after the presentation.
Henry Schein (Nasdaq: HSIC), the leading provider of healthcare solutions for dental and medical practitioners, has received validation for its net-zero science-based emissions reduction targets from the Science Based Targets initiative (SBTi).
The company's near-term commitments include:
- 42% reduction in absolute scope 1 GHG emissions by 2030 (2022 base year)
- Increasing renewable electricity sourcing from 0% to 100% by 2030
- 51.6% reduction in scope 3 GHG emissions per million USD value added by 2030
For long-term net-zero targets by 2050, Henry Schein commits to:
- 90% reduction in absolute scope 1 GHG emissions
- Maintaining 100% renewable electricity sourcing
- 97% reduction in scope 3 GHG emissions per million USD value added